The risk for moderate neutropenia associated with clozapine therapy is low in patients with treatment-resistant schizophrenia, and the risk for severe neutropenia is minimal, new research showed. None ...
Monitoring absolute neutrophil count (ANC) levels beyond 2 years of clozapine treatment is no longer necessary, new international guidelines stated. While low ANC levels — associated with severe ...
Main Outcomes of the FRESH START Trial: A Sequentially Tailored, Diet and Exercise Mailed Print Intervention Among Breast and Prostate Cancer Survivors A total of 190 patients (49 smokers, 141 ...
Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive metastatic breast cancer patients. The PATINA trial showed a median ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results